News
- 2026/02/10
- Noile-Immune Biotech Inc. has elucidated the mechanism by which PRIME CAR-T cells demonstrate superior therapeutic effects against solid cancers through collaborative research with the Department of Immunology, Yamaguchi University Graduate School of Medicine and hereby announces that these findings have been published in Cancer Immunology, Immunotherapy.
- The details is shown here>